Stockpickr

Return to Article

Cramer's Take on Headline Stocks

Stockpickr Staff

Bernard Madoff, perpetrator of the multibillion-dollar Ponzi scheme that destroyed the financial health of hundreds, even thousands, of people, received a 150-year jail sentence on Monday morning.

Also making headlines, Microsoft(MSFT Quote) might unload a 2007 acquisition, Razorfish, to a French marketing company. Microsoft closed up 51 cents, or $2.18, at $23.86 on Monday.

Swiss drug company Novartis(NVS Quote) is reportedly considering a purchase of Elan's(ELN Quote) multiple sclerosis treatment, Tsyabri, and other operations from the Irish biotech. Novartis closed down 17 cents at $41.17 on Monday, while Elan slid 41 cents, or 5.6%, to $6.95

And in analyst upgrade-downgrade news, Deutsche Bank downgraded Biogen Idec(BIIB Quote) to hold from buy, Friedman Billings Ramsey downgraded Alcoa(AA Quote) to underperform, and Credit Suisse upgraded KB Home(KBH Quote) to neutral from underperform.

Biogen lost $2.75, or 5.5%, on Monday to close at $47.32; Alcoa slid 32 cents, or 3%, to $10.44; and KB Home added 69 cents, or 5.1%, to $14.11.

With this in mind, we thought we'd take a look at some of the stocks in the news and see what Jim Cramer's had to say about them lately.

To read more, visit Stockpickr.com.